wbf943 wbf943

wbf943 wbf943

Guest researcher, Guest Researcher

Member of:


    Publication year:
    All
    1 - 2 out of 2Page size: 100
    1. 2018
    2. Published

      GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

      Gasbjerg, Lærke Smidt, Christensen, Mikkel Bring, Hartmann, Bolette, Lanng, A. R., wbf943, wbf943, Gabe, M. B. N., Dela, Flemming, Vilsbøll, Tina, Holst, Jens Juul, Rosenkilde, Mette & Knop, Filip Krag, Feb 2018, In: Diabetologia. 61, 2, p. 413-423

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Postprandial effects of individual and combined GIP and GLP-1 receptor antagonism in healthy subjects

      Gasbjerg, Lærke Smidt, Helsted, M. M., wbf943, wbf943, Lanng, A. R., Stensen, S., Jakobsen, M. H., Hartmann, Bolette, Christensen, Mikkel Bring, Holst, Jens Juul, Vilsbøll, Tina, Rosenkilde, M. M. & Knop, Filip Krag, 2018, In: Diabetologia. 61, S1, p. S246-S246 503.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    ID: 33841862